Filing Details

Accession Number:
0001348362-25-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-30 11:23:09
Reporting Period:
2025-07-29
Filing Date:
2025-07-30
Accepted Time:
2025-07-30 11:23:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348362 Lexaria Bioscience Corp. LEXX Pharmaceutical Preparations (2834) 202000871
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1855763 Vanessa Carle 100 - 740 Mccurdy Road
Kelowna A1 V1X 2P7
Secretary No Yes No No
Transaction Summary
Purchased: 750 shares Avg. Price: $0.91 Total Value: $682.50
Number of Shares After Transactions: 750 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2025-07-29 750 $0.91 750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Stock Options $3.00 2021-04-26 2026-04-26 12,500 12,500 Direct
Common Shares Stock Options $3.00 2021-06-08 2026-06-08 5,000 17,500 Direct
Common Shares Stock Options $3.00 2021-09-01 2026-09-01 10,000 27,500 Direct
Common Shares Stock Options $2.91 2022-08-29 2027-08-29 12,500 40,000 Direct
Common Shares Stock Options $1.15 2023-10-26 2028-10-26 10,000 50,000 Direct
Common Shares Stock Options $2.36 2024-04-26 2029-04-26 10,000 60,000 Direct
Common Shares Stock Options $1.04 2025-05-15 2030-05-15 15,000 75,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-04-26 12,500 12,500 Direct
2026-06-08 5,000 17,500 Direct
2026-09-01 10,000 27,500 Direct
2027-08-29 12,500 40,000 Direct
2028-10-26 10,000 50,000 Direct
2029-04-26 10,000 60,000 Direct
2030-05-15 15,000 75,000 Direct